Open AccessSZN-413, a FZD4 Agonist, as a Potential Novel Therapeutic for the Treatment of Diabetic Retinopathy
Author(s) -
Huy Nguyen,
Hui Chen,
Meghah Vuppalapaty,
Elizabeth Whisler,
Kelsey Ronarda Logas,
S. Parthasarathy,
Russell B. Fletcher,
Asmiti Sura,
Nicholas Suen,
Suhani Gupta,
Tom Lopez,
Jay Ye,
Shengjiang Tu,
Menaka Bolaki,
Wen-Chen Yeh,
Yang Li,
SungJin Lee
Publication year - 2022
Publication title -
translational vision science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 21
ISSN - 2164-2591
DOI - 10.1167/tvst.11.9.19
Subject(s) - diabetic retinopathy , agonist , retinal , neovascularization , retinopathy , medicine , retina , wnt signaling pathway , vascular permeability , endocrinology , pharmacology , receptor , signal transduction , ophthalmology , biology , angiogenesis , microbiology and biotechnology , neuroscience , diabetes mellitus